| 标题 |
Long-term results of a phase 2 study of neoadjuvant chemotherapy combined with tislelizumab followed by radiotherapy for bladder-preserving treatment in selected high-risk/locally advanced muscle invasive urothelial bladder cancer (HOPE-02)
|
| 网址 |
求助人暂未提供
|
| DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
| 其它 | 2025年ASCO大会poster 786 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)